XML 14 R2.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONDENSED INTERIM BALANCE SHEETS - USD ($)
May 31, 2021
Aug. 31, 2020
Current    
Cash and cash equivalents $ 325,156 $ 45,528
Marketable securities 15,204 24,354
Accounts receivable 3,940 1,508
Prepaid expenses and deposit 88,107 14,824
Total current assets 432,407 86,214
Non-Current    
Patents 69,000  
Total Assets 501,407 86,214
Current    
Accounts payable 282,803 290,336
Due to related parties 137,909 188,834
Total Current Liabilities 420,712 479,170
STOCKHOLDERS' EQUITY    
Share capital Authorized: 200,000,000 common shares with a par value of $0.001 per share Issued and outstanding: 136,431,700 common shares at May 31, 2021 and August 31,2020: 128,471,700 518,258 128,473
Additional paid-in capital 14,006,152 13,758,598
Deficit accumulated during the exploration stage (14,443,715) (14,280,027)
Total Stockholders' Equity 80,695 (392,956)
Total Liabilities and Stockholders' Equity 501,407 86,214
Commitments